Orally Active Benzamide Antipsychotic Agents with Affinity for Dopamine D2, Serotonin 5-HT1A, and Adrenergic α1 Receptors-Reference-Cited by-同舟云学术

Orally Active Benzamide Antipsychotic Agents with Affinity for Dopamine D2, Serotonin 5-HT1A, and Adrenergic α1 Receptors

Published:1998-05-01 Issue:12 Volume:41 Page:1997-2009
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Reitz Allen B.¹,Baxter Ellen W.¹,Codd Ellen E.¹,Davis Coralie B.¹,Jordan Alfonzo D.¹,Maryanoff Bruce E.¹,Maryanoff Cynthia A.¹,McDonnell Mark E.¹,Powell Eugene T.¹,Renzi Michael J.¹,Schott Mary R.¹,Scott Malcolm K.¹,Shank Richard P.¹,Vaught Jeffry L.¹

Affiliation:

1. Drug Discovery Division, R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm970164z

Reference66 articles.

1. Cost Considerations in the Treatment of Schizophrenia

2. (d) Meltzer, H. Y.Psychopharmacology: The ThirdGeneration of Progress;Raven Press: New York, 1987.

3. Developments in the drug treatment of schizophrenia

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of 2-chloro-benzamides for evaluation antimicrobial and disinfectant activity: Part-I;Current Trends in Pharmacy and Pharmaceutical Chemistry;2024-02-15

2. Design of P-Chirogenic Aminophosphine–Phosphinite Ligands at Both Phosphorus Centers: Origin of Enantioselectivities in Pd-Catalyzed Allylic Reactions;The Journal of Organic Chemistry;2020-05-05

3. Dopamine D 2 Partial Agonists – Discovery, Evolution, and Therapeutic Potential;Successful Drug Discovery;2019-07-19

4. Discovery of N-{2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N′-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor;Chemical and Pharmaceutical Bulletin;2018

5. The Effect of Carboxamide/Sulfonamide Replacement in Arylpiperazinylalkyl Derivatives on Activity to Serotonin and Dopamine Receptors;Archiv der Pharmazie;2017-08-28